A Study to Evaluate EDP-235 in Non-hospitalized Adults With COVID-19
Public ClinicalTrials.gov record NCT05616728. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Effects of EDP-235 in Non-hospitalized Adults With Mild or Moderate COVID-19
Study identification
- NCT ID
- NCT05616728
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Enanta Pharmaceuticals, Inc
- Industry
- Enrollment
- 231 participants
Conditions and interventions
Conditions
Interventions
- EDP-235 Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 64 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 9, 2022
- Primary completion
- Feb 7, 2023
- Completion
- Jun 28, 2023
- Last update posted
- Aug 18, 2024
2022 – 2023
United States locations
- U.S. sites
- 22
- U.S. states
- 5
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Torrance Clinical Research Institute | Lomita | California | 90717 | — |
| LA Universal Research Center, Inc. | Los Angeles | California | 90057 | — |
| MedBio Trials - Miami | Aventura | Florida | 33180 | — |
| Doral Medical Research | Doral | Florida | 33166 | — |
| Encore Medical Research - Hollywood | Hollywood | Florida | 33021-6467 | — |
| Universal Medical and Research Center, LLC | Hollywood | Florida | 33021 | — |
| Advanced Research for Health Improvement, LLC | Immokalee | Florida | 34142 | — |
| LCC Medical Research - Miami - ClinEdge - PPDS | Miami | Florida | 33126-1921 | — |
| USPA Advance Concept Medical Research Group. LLC | Miami | Florida | 33143 | — |
| Continental Clinical Research, LLC | Miami | Florida | 33144 | — |
| Dynamic Medical Research, LLC - Miami | Miami | Florida | 33144 | — |
| BioClinical Research Alliance | Miami | Florida | 33155-6542 | — |
| D&H National Research Centers | Miami | Florida | 33155 | — |
| Florida International Medical Research | Miami | Florida | 33155 | — |
| C'A Medical Center Inc Research | Miami | Florida | 33174-2968 | — |
| Reed Medical Research | Miami | Florida | 33176 | — |
| CDC Research Institute, LLC | Port Saint Lucie | Florida | 34952-7536 | — |
| Carolina Research Center | Shelby | North Carolina | 28150 | — |
| Toledo Institute of Clinical Research | Toledo | Ohio | 43617 | — |
| Trio Clinical Trials LLC | Houston | Texas | 77008-1393 | — |
| SMS Clinical Research, LLC | Mesquite | Texas | 75149 | — |
| Epic Medical Research | Red Oak | Texas | 75154 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05616728, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 18, 2024 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05616728 live on ClinicalTrials.gov.